Caption Management »

Crispr Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $28k 600 46.98
2024-06-30 $12M 214k 54.01
2024-03-31 $46M 680k 68.16
2023-12-31 $61M 981k 62.60
2023-09-30 $5.8M 127k 45.39
2023-06-30 $19M 330k 56.14
2022-12-31 $1.0M 25k 40.65
2022-09-30 $4.2M 65k 65.35
2022-06-30 $4.9M 80k 60.77
2022-03-31 $2.5M 40k 62.80
2021-12-31 $3.3M 44k 75.80
2021-06-30 $13M 82k 161.90
2021-03-31 $5.2M 43k 121.86
2020-06-30 $13M 175k 73.51
2020-03-31 $4.2M 100k 42.41
2019-12-31 $6.1M 100k 60.91
2018-09-30 $639k 14k 44.36
2018-06-30 $847k 14k 58.83